Sixth Street $800 million preferred equity investment in BridgeBio

Sixth Street funded $800 million as lead investor in BridgeBio's newly issued convertible preferred equity. HealthCare Royalty funded a separate $133.9 million. The stated amount represents Sixth Street's own funded investment, rather than the financing's up-to-$1 billion capacity.